Capital Advisors Ltd. LLC raised its holdings in shares of Vanguard Mega Cap ETF (NYSEARCA:MGC – Free Report) by 24.9% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,840 shares of the company’s stock after buying an additional 367 shares during the period. Capital Advisors Ltd. LLC’s holdings in Vanguard Mega Cap ETF were worth $344,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Key Financial Inc purchased a new stake in shares of Vanguard Mega Cap ETF in the 4th quarter valued at approximately $29,000. Voisard Asset Management Group Inc. purchased a new stake in Vanguard Mega Cap ETF in the 4th quarter worth approximately $30,000. Future Financial Wealth Managment LLC purchased a new stake in Vanguard Mega Cap ETF in the 1st quarter worth approximately $37,000. Acima Private Wealth LLC purchased a new stake in Vanguard Mega Cap ETF in the 4th quarter worth approximately $40,000. Finally, Principal Securities Inc. purchased a new stake in Vanguard Mega Cap ETF in the 4th quarter worth approximately $55,000.
Vanguard Mega Cap ETF Stock Up 0.7 %
MGC stock opened at $199.62 on Wednesday. Vanguard Mega Cap ETF has a 12-month low of $145.94 and a 12-month high of $199.70. The company has a market cap of $5.76 billion, a price-to-earnings ratio of 26.93 and a beta of 1.02. The company has a 50 day moving average of $190.55 and a two-hundred day moving average of $182.48.
Vanguard Mega Cap ETF Profile
The Vanguard Mega Cap ETF (MGC) is an exchange-traded fund that is based on the CRSP US Mega Cap index, a market-cap-weighted index that covers 70% of the market capitalization of the US equity market. MGC was launched on Dec 24, 2007 and is managed by Vanguard.
Featured Stories
- Five stocks we like better than Vanguard Mega Cap ETF
- How to Calculate Inflation Rate
- Does BJ’s Wholesale Club Stock Have More Room to Grow?
- How to Invest in Biotech Stocks
- Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
- How to Most Effectively Use the MarketBeat Earnings Screener
- RXO Shares Surge Following New Acquisition Deal
Receive News & Ratings for Vanguard Mega Cap ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard Mega Cap ETF and related companies with MarketBeat.com's FREE daily email newsletter.